Paola Forti

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Journal: Journal of neurology

Published: May 20, 2026

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Journal: JAMA network open

Published: April 28, 2026

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Journal: Neurology

Published: April 13, 2026

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Journal: Journal of the neurological sciences

Published: April 01, 2026

Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis.

Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis.

Journal: Journal of the American Heart Association

Published: March 31, 2026

Geriatric team support in the emergency department-a randomised trial investigating the effects on hospital admission and community care in older adults (GerED-21).

Geriatric team support in the emergency department-a randomised trial investigating the effects on hospital admission and community care in older adults (GerED-21).

Journal: Age and ageing

Published: January 05, 2026

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Journal: European stroke journal

Published: November 20, 2025

Enhancing prognostic models for stroke outcomes in older patients: Insights from Prestroke frailty and disability assessments.

Enhancing prognostic models for stroke outcomes in older patients: Insights from Prestroke frailty and disability assessments.

Journal: Journal of the neurological sciences

Published: August 13, 2025

Causal inference concerns in comparing prestroke frailty and disability for outcome prediction.

Causal inference concerns in comparing prestroke frailty and disability for outcome prediction.

Journal: Journal of the neurological sciences

Published: August 10, 2025

The proBNPage reduction (PBAR) trial-results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatments.

The proBNPage reduction (PBAR) trial-results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatments.

Journal: GeroScience

Published: June 16, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026